UnitedHealth Group Incorporated (NYSE:UNH) is one of the stocks Jim Cramer recently gave takes on. A caller asked if the stock is still a buy, and Cramer remarked:
“Okay, so UNH, when I read that they are throwing their weight around in Washington and spending a lot of time with the, in the executive offices and really spending a, really making a point of touching bases with all the people who might be able to rub up against some of the people who are trying to hurt them, like maybe prosecutors, it makes me feel that UNH is bottomed. And I did think that they would be, they could have the death sentence of being investigated for Medicare fraud. It does seem like that might be off the table. I don’t, do I want to go buy it here? I would, if I bought it, I would buy with calls. I would not buy with common stock.”
Ken Wolter/Shutterstock.com
UnitedHealth Group Incorporated (NYSE:UNH) provides health insurance plans, pharmacy benefits, and care services across diverse customer groups. It also delivers technology, data, and consulting solutions through its Optum businesses.
While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.